This inventor holds 5 USPTO granted patents. Top assignee: Tanabe Seiyaku Company, Limited. Active years: 1993-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Chiyoda, JP (1995)
- Tokyo, JP (1993 - 1996)
- Tokyo-to, JP (1999)
Company Filing History:
Years Active: 1993-1999
Title: Kazuaki Naito: Innovator in Pharmaceutical Chemistry
Introduction
Kazuaki Naito is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of 5 patents to his name, Naito's work has the potential to impact the treatment of various health conditions.
Latest Patents
Among his latest innovations are pyridine derivatives, which exhibit excellent bronchoconstriction inhibitory activity and anti-inflammatory properties for the treatment of asthma. These compounds are characterized by a specific formula that includes various functional groups, making them versatile in their application. Another notable patent is for imidazopyridine derivatives, which are designed for the prophylaxis and treatment of hypertension. This compound also features a unique structure that enhances its therapeutic efficacy.
Career Highlights
Kazuaki Naito is currently associated with Tanabe Seiyaku Company, Limited, where he continues to advance his research and development efforts. His work at this esteemed company has allowed him to focus on creating innovative solutions for pressing health issues.
Collaborations
Naito has collaborated with several esteemed colleagues, including Yasushi Honma and Yasuo Sekine. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Kazuaki Naito's contributions to pharmaceutical chemistry through his innovative patents demonstrate his commitment to improving healthcare solutions. His work continues to pave the way for advancements in the treatment of asthma and hypertension.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile